Literature DB >> 5416168

Pharmacokinetic profile of coumermycin A.

S A Kaplan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5416168     DOI： 10.1002/jps.2600590306

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  10 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

2.  Application of the Loo-Riegelman absorption method.

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1975-02

3.  Activity of intracellular antibiotics.

Authors:  P Van der Auwera; G Prinz; G Petrikkos
Journal:  Infection       Date:  1991       Impact factor: 3.553

4.  Linear pharmacokinetic models: geometric construction to determine transfer and elimination rate constants.

Authors:  N P Chau
Journal:  J Pharmacokinet Biopharm       Date:  1977-04

5.  Mathematical basis and generalization of the Loo-Riegelman method for the determination of in vivo drug absorption.

Authors:  D P Vaughan; M Dennis
Journal:  J Pharmacokinet Biopharm       Date:  1980-02

6.  Gyrase B inhibitor impairs HIV-1 replication by targeting Hsp90 and the capsid protein.

Authors:  Luciano Vozzolo; Belinda Loh; Paul J Gane; Maryame Tribak; Lihong Zhou; Ian Anderson; Elisabeth Nyakatura; Richard G Jenner; David Selwood; Ariberto Fassati
Journal:  J Biol Chem       Date:  2010-10-11       Impact factor: 5.157

7.  Antibacterial activity of coumermycin alone and in combination with other antibiotics.

Authors:  H C Neu; N X Chin; P Labthavikul
Journal:  Antimicrob Agents Chemother       Date:  1984-06       Impact factor: 5.191

8.  Treatment of Staphylococcus aureus endocarditis in rats with coumermycin A1 and ciprofloxacin, alone or in combination.

Authors:  C M Perronne; R Malinverni; M P Glauser
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

9.  Activity of coumermycin against clinical isolates of staphylococci.

Authors:  M N Guillemin; H M Miles; M I McDonald
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

10.  HIV-1 capsid is involved in post-nuclear entry steps.

Authors:  Nan-Yu Chen; Lihong Zhou; Paul J Gane; Silvana Opp; Neil J Ball; Giuseppe Nicastro; Madeleine Zufferey; Cindy Buffone; Jeremy Luban; David Selwood; Felipe Diaz-Griffero; Ian Taylor; Ariberto Fassati
Journal:  Retrovirology       Date:  2016-04-23       Impact factor: 4.602
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.